Literature DB >> 19423735

Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS.

Anders Helander1, Yufang Zheng.   

Abstract

BACKGROUND: The alcohol biomarker phosphatidylethanol (PEth) comprises a group of ethanol-derived phospholipids formed from phosphatidylcholine by phospholipase D. The PEth molecular species have a common phosphoethanol head group onto which 2 fatty acid moieties are attached. We developed an electrospray ionization (ESI) LC-MS method for qualitative and quantitative measurement of different PEth species in human blood.
METHODS: We subjected a total lipid extract of whole blood to HPLC gradient separation on a C4 column and performed LC-ESI-MS analysis using selected ion monitoring of deprotonated molecules for the PEth species and phosphatidylpropanol (internal standard). Identification of individual PEth species was based on ESI-tandem mass spectrometry (MS/MS) analysis of product ions.
RESULTS: The fatty acid moieties were the major product ions of PEth, based on comparison with PEth-16:0/16:0, 18:1/18:1, and 16:0/18:1 reference material. For LC-MS analysis of different PEth species in blood, we used a calibration curve covering 0.2-7.0 micromol/L PEth-16:0/18:1. The lower limit of quantitation of the method was <0.1 micromol/L, and intra- and interassay CVs were <9% and <11%. In blood samples collected from 38 alcohol patients, the total PEth concentration ranged between 0.1 and 21.7 micromol/L (mean 8.9). PEth-16:0/18:1 and 16:0/18:2 were the predominant molecular species, accounting for approximately 37% and 25%, respectively, of total PEth. PEth-16:0/20:4 and mixtures of 18:1/18:1 plus 18:0/18:2 (not separated using selected ion monitoring because of identical molecular masses) and 16:0/20:3 plus 18:1/18.2 made up approximately 13%, 12%, and 8%.
CONCLUSIONS: This LC-MS method allows simultaneous qualitative and quantitative measurement of several PEth molecular species in whole blood samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423735     DOI: 10.1373/clinchem.2008.120923

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  32 in total

1.  Investigation of chronic alcohol consumption in rodents via ultra-high-performance liquid chromatography-mass spectrometry based metabolite profiling.

Authors:  Helen G Gika; Cheng Ji; Georgios A Theodoridis; Filippos Michopoulos; Neil Kaplowitz; Ian D Wilson
Journal:  J Chromatogr A       Date:  2012-03-03       Impact factor: 4.759

2.  Stability of Phosphatidylethanol in Dry Blood Spot Cards.

Authors:  Ludmila N Bakhireva; Shikhar Shrestha; Hilda L Gutierrez; Mike Berry; Cheryl Schmitt; Dusadee Sarangarm
Journal:  Alcohol Alcohol       Date:  2015-10-29       Impact factor: 2.826

3.  Phosphatidylethanol Levels Among Incarcerated Women: The Influence of Pre-incarceration Alcohol Consumption and Length of Abstinence.

Authors:  Kelly E Moore; Olga J Santiago Rivera; Bradley Anderson; Jennifer E Johnson; Judith A Hahn; Megan E Kurth; Madhavi K Reddy; Yael C Schonbrun; Michael D Stein
Journal:  Alcohol Clin Exp Res       Date:  2018-01-31       Impact factor: 3.455

Review 4.  Alcohol Biomarkers in Clinical and Forensic Contexts.

Authors:  Hilke Andresen-Streichert; Alexander Müller; Alexander Glahn; Gisela Skopp; Martina Sterneck
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

5.  Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.

Authors:  Judith A Hahn; Loren M Dobkin; Bernard Mayanja; Nneka I Emenyonu; Isaac M Kigozi; Stephen Shiboski; David R Bangsberg; Heike Gnann; Wolfgang Weinmann; Friedrich M Wurst
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

6.  Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol-a drinking study with 16 volunteers.

Authors:  Alexandra Schröck; Annette Thierauf-Emberger; Stefan Schürch; Wolfgang Weinmann
Journal:  Int J Legal Med       Date:  2016-09-05       Impact factor: 2.686

7.  Differences in the Synthesis and Elimination of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 After Acute Doses of Alcohol.

Authors:  Nathalie Hill-Kapturczak; Donald M Dougherty; John D Roache; Tara E Karns-Wright; Martin A Javors
Journal:  Alcohol Clin Exp Res       Date:  2018-03-30       Impact factor: 3.455

8.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

9.  Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.

Authors:  Martin A Javors; Nathalie Hill-Kapturczak; John D Roache; Tara E Karns-Wright; Donald M Dougherty
Journal:  Alcohol Clin Exp Res       Date:  2016-04-30       Impact factor: 3.455

10.  Stability of phosphatidylethanol species in spiked and authentic whole blood and matching dried blood spots.

Authors:  Andrea Faller; Barbara Richter; Matthias Kluge; Patrick Koenig; H K Seitz; Gisela Skopp
Journal:  Int J Legal Med       Date:  2012-12-04       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.